Allogeneic haematopoietic stem cell transplantation for adult T‐lymphoblastic lymphoma: A real‐world multicentre analysis in China

Documenti analoghi

• Up‐front autologous stem cell transplant in peripheral T‐cell lymphoma patients achieving complete response after first‐line treatment: A multicentre real‐world analysis
  di: Peipei Yang, et al.
  Pubblicazione: (2024)
• Comprehensive risk stratification for adult T‐cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation
  di: Fangfang Yu, et al.
  Pubblicazione: (2025)
• Long‐term outcomes after allogeneic versus autologous haematopoietic stem cell transplantation for T‐lymphoblastic lymphoma
  di: Qian Cheng, et al.
  Pubblicazione: (2026)
• Contrasting impacts of pretransplant cytoreduction and post‐transplant maintenance on outcomes of allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes: Real‐world multicentre evidence
  di: Yilin Chen, et al.
  Pubblicazione: (2026)
• A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy
  di: Xing‐yu Cao, et al.
  Pubblicazione: (2024)